Rospatent IP News Digest March 2022
Latest trends of filing activity in Russia
Recent statistics for January-February 2022 show positive dynamics of filing activity in Russia compared to the respective period of 2021.
The number of filed trademark applications increased by 14.7%, (14,949 applications). Russian residents filed 23.6% more applications (11,190 applications). The number of applications filed by foreign applicants to Rospatent directly increased by 8.2% (1,433 applications). The average duration of examination of these applications decreased from 4.17 months to 3.89 months.
The number of applications for inventions increased by 6.6% (3,818 applications). Russian residents filed 4.4% more applications (2,222 applications), while foreign residents filed 9.9% more applications (1,596 applications).
The number of applications for utility models increased by 16.4%, (1,190 applications). Russian residents filed 15.9% more applications (1,161 applications), while foreign residents filed 45% more applications (29 applications).
3,007 applications for computer programs, databases, and topographies were filed, which is 10.5% more than a year earlier. Russian residents filed 10.2% more applications and foreign applicants filed 77.8% more applications.
Spam calls is an annoyance which probably everyone has experienced. Spammers often do not use the services of live operators in call centers; instead, they rely on chatbots that make calls to telephone numbers from databases and reproduce advertising messages.
The recent invention of Kaspersky Lab uses artificial intelligence technologies to combat spam calls. A pre-trained call classification model generates a record of incoming call media data and converts it into a set of attributes that make it possible to determine the nature of the call. If the call has obvious signs of a spam call, the program automatically blocks it.
Rospatent meets with the Association of European Businesses
On March 17, 2022 the Head of Rospatent Yury Zubov and Deputy Head of Rospatent Victoria Galkovskaya met with CEO of the Association of European Businesses (AEB) Mr. Tadzio Schilling. The meeting was also attended by representatives of various companies, 2 AEB Committees – Intellectual Property and Healthcare, as well as the President of the Eurasian Patent Office Mr. Grigory Ivliev.
The parties noted the crucial importance of intellectual property for economic development and provision of Russian consumers with quality goods, including medicines. The participants exchanged information on approaches to introduction of parallel import of goods and prospects of introduction of the register of pharmacologically active substances at the Russian and Eurasian levels.
On March 1, 2022, the Regulation on Accreditation came into force, which enables Rospatent to accredit Russian scientific or educational organizations that wish to carry out preliminary information search for claimed inventions or utility models, as well as preliminary assessment of patentability.
On March 24, 2022, Rospatent received the first application for accreditation from the Volgograd State Medical University. Applications for accreditation from other Russian universities and scientific organizations are expected to arrive in the near future.
Preliminary information search and preliminary assessment of patentability is a mechanism recently introduced in Russia that is expected to accelerate examination and raise quality of patents for niche and complex technical solutions.
Rospatent launches a new digital platform
Rospatent has launched a new digital platform for patent information search available for the general public.
The new search platform allows the search for information in global patent databases, including Russia and CIS countries’ bulk data, multilingual full-text and attribute search in major European languages, search based on patent classifiers, search using artificial intelligence, search by chemical formulas, genetic sequences, etc. For developers, an API has been put in place.
Analytical services are also available on the platform, allowing to monitor the indicators of intellectual property sphere.
The platform can be reached at: https://searchplatform.rospatent.gov.ru/
XXV Moscow International Fair of Inventions and Innovative Technologies “Archimedes”
Head of Rospatent Yury Zubov spoke at the opening of the XXV Moscow International Fair of Inventions and Innovative Technologies “Archimedes”, held on 29-31 March 2022.
In his speech, Head of Rospatent highlighted the successes in digitalization of the Office. The main goal of this process is to create a unified digital environment for interaction with all categories of customers featuring convenient service interfaces across the entire range of public services.
The fact that “Archimedes” has been held for more than 20 years clearly shows that it has earned high recognition of Russian and foreign inventors, manufacturers and consumers of innovative products. Every year inventors from dozens of countries take part in this fair to demonstrate their latest developments.
On March 30, at “Archimedes” Rospatent held a scientific and practical conference entitled “Management of IP rights, or how to make intellectual property work”.
Remedy to treat tissue fibrosis
Fibrosis is a medical term that denotes the formation of adhesions and scars in tissues caused by lesions of various nature (mechanical, thermal, chemical, etc.). During the pandemic, fibrosis has been a complication of pneumonia in about 10% of patients with COVID-19. Some researchers believe that fibrosis is a symptom of early lung aging, leading to the development of respiratory and circulatory system diseases.
The remedy patented by scientists from the Moscow State University is based on components of the secretome of mesenchymal stromal cells (MSCs), which have a complex effect on the regenerative processes in a body. MSCs secretome stimulate the launch of a body’s inherent recovery mechanisms, while simultaneously suppressing the proliferation of scarred tissues in various organs. To achieve this effect, MSCs of adipose tissue are used, since they generate an optimal combination of active components that contribute to the prevention of tissue fibrosis.
Considering both the consequences of the COVID-19 pandemic and the number of pneumonia cases, it is possible to predict a high demand for medicines based on this new invention.
Related news
